(Stroke. 2001;32:1793.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Stroke Unit (G.J.H.), Department of Neurology, Royal Perth Hospital, Perth, Australia; Thrombosis and Haemophilia Service (J.W.E., E.L., N.S., R.I.B.), Royal Perth Hospital, Perth, Australia; and Cardiovascular Genetics Laboratory (F.M.v.B.), Clinical Pathology and Biochemistry, Royal Perth Hospital, and Department of Pathology, University of Western Australia, Perth, Australia.
Correspondence to John Eikelboom, Department of Haematology, Royal Perth Hospital, Box X2213 GPO, Perth WA 6001, Australia. E-mail johneikelboom{at}eftel.com.au
Background and Purpose One or more of the inherited thrombophilias may be causal risk factor for a proportion of ischemic strokes, but few studies have addressed this association or the association between thrombophilia and pathogenic subtypes of stroke.
Methods We conducted a case-control study of 219 hospital cases with a first-ever ischemic stroke and 205 randomly selected community control subjects stratified by age, sex, and postal code. With the use of established criteria, cases of stroke were classified by pathogenic subtype in a blinded fashion. The prevalence of conventional vascular risk factors; fasting plasma levels of protein C, protein S, antithrombin III; and genetic tests for the factor V Leiden and the prothrombin 20210A mutation were determined in cases and control subjects.
Results The prevalence of any thrombophilia was 14.7% (95% CI, 9.9% to 19.5%) among cases and 11.7% (95% CI, 7.4% to 17.0%) among control subjects (OR, 1.3; 95% CI, 0.7% to 2.3%). The prevalence of individual thrombophilias among cases ranged from 0.9% (95% CI, 0.1% to 3.4%) for protein S deficiency to 5.2% (95% CI, 0.3% to 9.1%) for antithrombin III deficiency; among control subjects, the prevalence ranged from 1.0% (95% CI, 0.1% to 3.6%) for protein S deficiency to 4.1% (95% CI, 0.2% to 7.8%) for antithrombin III deficiency. There were no significant differences in the prevalence of thrombophilia between cases and control subjects or between pathogenic subtypes of ischemic stroke.
Conclusions One in 7 patients with first-ever acute ischemic stroke will test positive for one of the inherited thrombophilias, but the relation is likely to be coincidental rather than causal in almost all cases, irrespective of the pathogenic subtype of the ischemic stroke. These results suggest that routine testing for thrombophilia in most patients with acute ischemic stroke may be unnecessary. Whether the thrombophilias may still be important in younger patients with ischemic stroke or in predicting complications (eg, venous thrombosis) and stroke outcome remains uncertain.
Key Words: cerebral infarction stroke classification thrombophilia
This article has been cited by other articles:
![]() |
E. Berge, K. B. F. Haug, E. Charlotte Sandset, K. Kristine Haugbro, M. Turkovic, and P. M. Sandset The Factor V Leiden, Prothrombin Gene 20210GA, Methylenetetrahydrofolate Reductase 677CT and Platelet Glycoprotein IIIa 1565TC Mutations in Patients With Acute Ischemic Stroke and Atrial Fibrillation Stroke, March 1, 2007; 38(3): 1069 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation, March 14, 2006; 113(10): e409 - e449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, February 1, 2006; 37(2): 577 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Carod-Artal, S. V. Nunes, D. Portugal, T. V. F. Silva, and A. P. Vargas Ischemic Stroke Subtypes and Thrombophilia in Young and Elderly Brazilian Stroke Patients Admitted to a Rehabilitation Hospital Stroke, September 1, 2005; 36(9): 2012 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Lynch, C. J. Han, L. E. Nee, and K. B. Nelson Prothrombotic Factors in Children With Stroke or Porencephaly Pediatrics, August 1, 2005; 116(2): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Butler and R. Neilson Thrombophilia Screening and Ischemic Stroke Arch Intern Med, December 13, 2004; 164(22): 2502 - 2502. [Full Text] [PDF] |
||||
![]() |
J. P. Casas, A. D. Hingorani, L. E. Bautista, and P. Sharma Meta-analysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls Arch Neurol, November 1, 2004; 61(11): 1652 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-H Tsai, W-P Tsai, S-T Liao, and L-b Liou Anticardiolipin antibodies in various diseases in Taiwan: a retrospective analysis Lupus, October 1, 2003; 12(10): 747 - 753. [Abstract] [PDF] |
||||
![]() |
G. J. Hankey and J. W. Eikelboom Editorial Comment--Routine Thrombophilia Testing in Stroke Patients Is Unjustified Stroke, August 1, 2003; 34(8): 1826 - 1827. [Full Text] [PDF] |
||||
![]() |
P. Jerrard-Dunne, A. Evans, R. McGovern, C. Hajat, L. Kalra, A. G. Rudd, C. D. Wolfe, and H. S. Markus Ethnic Differences in Markers of Thrombophilia: Implications for the Investigation of Ischemic Stroke in Multiethnic Populations: The South London Ethnicity and Stroke Study Stroke, August 1, 2003; 34(8): 1821 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Chen, M.-Y. Lan, Y.-Y. Chang, S.-S. Chen, and J.-S. Liu The Prevalence of Protein C, Protein S, and Antithrombin III Deficiency in non-APS/SLE Chinese Adults with Noncardiac Cerebral Ischemia Clinical and Applied Thrombosis/Hemostasis, April 1, 2003; 9(2): 155 - 162. [Abstract] [PDF] |
||||
![]() |
K. Juul, A. Tybjarg-Hansen, R. Steffensen, S. Kofoed, G. Jensen, and B. G. Nordestgaard Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses Blood, June 17, 2002; 100(1): 3 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Bushnell and L. B. Goldstein Physician Knowledge and Practices in the Evaluation of Coagulopathies in Stroke Patients Stroke, April 1, 2002; 33(4): 948 - 953. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |